OGN) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 5.3% year on year to $1.51 billion ... Organon (OGN) Q4 CY2025 Highlights. ... OGN) is a global healthcare company focused on ...
Pharmaceutical company Organon (NYSE. OGN) will be announcing earnings results this Thursday morning. Here’s what you need to know ... Is Organon a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... More News ... .
What Happened?. Shares of pharmaceutical company Organon (NYSE. OGN) jumped 8.9% in the afternoon session after reports surfaced that Sun Pharmaceutical Industries submitted a non-binding proposal to acquire the company ... More News. ViewMore ... Tickers ATO.